scispace - formally typeset
Search or ask a question
Institution

Medical University of South Carolina

EducationCharleston, South Carolina, United States
About: Medical University of South Carolina is a education organization based out in Charleston, South Carolina, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 23436 authors who have published 45440 publications receiving 1769397 citations. The organization is also known as: MUSC & Medical College of the State of South Carolina.
Topics: Population, Poison control, Medicine, Cancer, Stroke


Papers
More filters
Journal ArticleDOI
15 Aug 2012-JAMA
TL;DR: Among patients with PTSD and substance dependence, the combined use of COPE plus usual treatment, compared with usual treatment alone, resulted in improvement in PTSD symptom severity without an increase in severity of substance dependence.
Abstract: Context There is concern that exposure therapy, an evidence-based cognitive-behavioral treatment for posttraumatic stress disorder (PTSD), may be inappropriate because of risk of relapse for patients with co-occurring substance dependence. Objective To determine whether an integrated treatment for PTSD and substance dependence, Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE), can achieve greater reductions in PTSD and substance dependence symptom severity compared with usual treatment for substance dependence. Design, Setting, and Participants Randomized controlled trial enrolling 103 participants who met DSM-IV-TR criteria for both PTSD and substance dependence. Participants were recruited from 2007-2009 in Sydney, Australia; outcomes were assessed at 9 months postbaseline, with interim measures collected at 6 weeks and 3 months postbaseline. Interventions Participants were randomized to receive COPE plus usual treatment (n = 55) or usual treatment alone (control) (n = 48). COPE consists of 13 individual 90-minute sessions (ie, 19.5 hours) with a clinical psychologist. Main Outcome Measures Change in PTSD symptom severity as measured by the Clinician-Administered PTSD Scale (CAPS; scale range, 0-240) and change in severity of substance dependence as measured by the number of dependence criteria met according to the Composite International Diagnostic Interview version 3.0 (CIDI; range, 0-7), from baseline to 9-month follow-up. A change of 15 points on the CAPS scale and 1 dependence criterion on the CIDI were considered clinically significant. Results From baseline to 9-month follow-up, significant reductions in PTSD symptom severity were found for both the treatment group (mean difference, −38.24 [95% CI, −47.93 to −28.54]) and the control group (mean difference, −22.14 [95% CI, −30.33 to −13.95]); however, the treatment group demonstrated a significantly greater reduction in PTSD symptom severity (mean difference, −16.09 [95% CI, −29.00 to −3.19]). No significant between-group difference was found in relation to improvement in severity of substance dependence (0.43 vs 0.52; incidence rate ratio, 0.85 [95% CI, 0.60 to 1.21), nor were there any significant between-group differences in relation to changes in substance use, depression, or anxiety. Conclusion Among patients with PTSD and substance dependence, the combined use of COPE plus usual treatment, compared with usual treatment alone, resulted in improvement in PTSD symptom severity without an increase in severity of substance dependence. Trial Registration isrctn.org Identifier: ISRCTN12908171

287 citations

Journal ArticleDOI
TL;DR: It is demonstrated that complement activation in the kidney after I/R occurs exclusively via the alternative pathway, and that selective inhibition of this pathway provides protection to the kidneys from ischemic ARF.
Abstract: Ischemia/reperfusion (I/R) injury of the kidney is a common cause of acute renal failure (ARF) and is associated with high morbidity and mortality in the intensive care unit. The mechanisms underlying I/R injury are complex. Studies have shown that complement activation contributes to the pathogenesis of I/R injury in the kidney, but the exact mechanisms of complement activation have not been defined. We hypothesized that complement activation in this setting occurs via the alternative pathway and that mice deficient in complement factor B, an essential component of the alternative pathway, would be protected from ischemic ARF. Wild-type mice suffered from a decline in renal function and had significant tubular injury, particularly in the outer medulla, after I/R. We found that factor B-deficient mice ( fB −/− ) developed substantially less functional and morphologic renal injury after I/R. Furthermore, control wild-type mice had an increase in tubulointerstitial complement C3 deposition and neutrophil infiltration in the outer medulla after I/R, whereas fB −/− mice demonstrated virtually no C3 deposition or neutrophil infiltration. Our results demonstrate that complement activation in the kidney after I/R occurs exclusively via the alternative pathway, and that selective inhibition of this pathway provides protection to the kidneys from ischemic ARF.

286 citations

Journal ArticleDOI
Christopher I. Amos1, Joe Dennis2, Zhaoming Wang3, Jinyoung Byun1, Fredrick R. Schumacher4, Simon A. Gayther5, Graham Casey6, David J. Hunter7, Thomas A. Sellers, Stephen B. Gruber6, Alison M. Dunning2, Kyriaki Michailidou2, Laura Fachal2, Kimberly F. Doheny8, Amanda B. Spurdle9, Yafang Li1, Xiangjun Xiao1, Jane Romm8, Elizabeth W. Pugh8, Gerhard A. Coetzee10, Dennis J. Hazelett5, Stig E. Bojesen11, Charlisse Caga-Anan, Christopher A. Haiman5, Ahsan Kamal1, Craig Luccarini2, Daniel C. Tessier12, Daniel Vincent12, Francois Bacot12, David Van Den Berg6, Stefanie A. Nelson, Stephen Demetriades13, David E. Goldgar14, Fergus J. Couch15, Judith L. Forman1, Graham G. Giles16, Graham G. Giles17, David V. Conti6, Heike Bickeböller18, Angela Risch19, Angela Risch20, Melanie Waldenberger, Irene Brüske-Hohlfeld, Belynda Hicks, Hua Ling8, Lesley McGuffog17, Lesley McGuffog16, Andy C. H. Lee2, Karoline Kuchenbaecker2, Penny Soucy21, Judith Manz, Julie M. Cunningham15, Katja Butterbach20, Zsofia Kote-Jarai22, Peter Kraft7, Liesel M. FitzGerald16, Liesel M. FitzGerald17, Sara Lindström23, Sara Lindström7, Marcia Adams8, James McKay24, Catherine M. Phelan, Sara Benlloch2, Linda E. Kelemen25, Paul Brennan24, Marjorie J. Riggan26, Tracy A. O'Mara9, Hongbing Shen27, Yongyong Shi28, Deborah J. Thompson2, Marc T. Goodman5, Sune F. Nielsen11, Andrew Berchuck26, Sylvie Laboissiere12, Stephanie L. Schmit29, Tameka Shelford8, Christopher K. Edlund6, Jack A. Taylor30, John K. Field31, Sue K. Park32, Kenneth Offit33, Kenneth Offit34, Kenneth Offit35, Mads Thomassen36, Rita K. Schmutzler, Laura Ottini37, Rayjean J. Hung38, Jonathan Marchini39, Ali Amin Al Olama2, Ulrike Peters40, Rosalind A. Eeles22, Michael F. Seldin41, Elizabeth M. Gillanders, Daniela Seminara, Antonis C. Antoniou2, Paul D.P. Pharoah2, Georgia Chenevix-Trench9, Stephen J. Chanock, Jacques Simard21, Douglas F. Easton2 
TL;DR: Results from these analyses will enable researchers to identify new susceptibility loci, perform fine-mapping of new or known loci associated with either single or multiple cancers, assess the degree of overlap in cancer causation and pleiotropic effects of loci that have been identified for disease-specific risk, and jointly model genetic, environmental, and lifestyle-related exposures.
Abstract: BACKGROUND: Common cancers develop through a multistep process often including inherited susceptibility. Collaboration among multiple institutions, and funding from multiple sources, has allowed the development of an inexpensive genotyping microarray, the OncoArray. The array includes a genome-wide backbone, comprising 230,000 SNPs tagging most common genetic variants, together with dense mapping of known susceptibility regions, rare variants from sequencing experiments, pharmacogenetic markers, and cancer-related traits. METHODS: The OncoArray can be genotyped using a novel technology developed by Illumina to facilitate efficient genotyping. The consortium developed standard approaches for selecting SNPs for study, for quality control of markers, and for ancestry analysis. The array was genotyped at selected sites and with prespecified replicate samples to permit evaluation of genotyping accuracy among centers and by ethnic background. RESULTS: The OncoArray consortium genotyped 447,705 samples. A total of 494,763 SNPs passed quality control steps with a sample success rate of 97% of the samples. Participating sites performed ancestry analysis using a common set of markers and a scoring algorithm based on principal components analysis. CONCLUSIONS: Results from these analyses will enable researchers to identify new susceptibility loci, perform fine-mapping of new or known loci associated with either single or multiple cancers, assess the degree of overlap in cancer causation and pleiotropic effects of loci that have been identified for disease-specific risk, and jointly model genetic, environmental, and lifestyle-related exposures. IMPACT: Ongoing analyses will shed light on etiology and risk assessment for many types of cancer. Cancer Epidemiol Biomarkers Prev; 26(1); 126-35. ©2016 AACR.

286 citations

Journal ArticleDOI
TL;DR: A randomized clinical trial evaluated the efficacy of multisystemic therapy (MST) versus usual community services (UCS) for 48 juvenile sexual offenders at high risk of committing additional serious crimes showed that MST was more effective than UCS in improving key family, peer, and academic correlates of juvenile sexual offending and in ameliorating adjustment problems in individual family members.
Abstract: A randomized clinical trial evaluated the efficacy of multisystemic therapy (MST) versus usual community services (UCS) for 48 juvenile sexual offenders at high risk of committing additional serious crimes. Results from multiagent assessment batteries conducted before and after treatment showed that MST was more effective than UCS in improving key family, peer, and academic correlates of juvenile sexual offending and in ameliorating adjustment problems in individual family members. Moreover, results from an 8.9-year follow-up of rearrest and incarceration data (obtained when participants were on average 22.9 years of age) showed that MST participants had lower recidivism rates than did UCS participants for sexual (8% vs. 46%, respectively) and nonsexual (29% vs. 58%, respectively) crimes. In addition, MST participants had 70% fewer arrests for all crimes and spent 80% fewer days confined in detention facilities than did their counterparts who received UCS. The clinical and policy implications of these findings are discussed.

286 citations

Journal ArticleDOI
TL;DR: It is shown that inactivation of the dorsolateral caudate–putamen, but not other structures previously implicated in reinstatement, attenuates cocaine seeking after abstinence, suggesting that there is limited overlap in the substrates of cocaineseeking after abstinence versus extinction, and that habit learning exerts greater control over drug seeking than regions implicated in stimulus–reward associations.
Abstract: Cue-induced reinstatement of extinguished drug seeking is a preclinical model of relapse. However, relapse typically occurs after abstinence rather than explicit extinction training. We show that inactivation of the dorsolateral caudate–putamen, but not other structures previously implicated in reinstatement, attenuates cocaine seeking after abstinence. This suggests that there is limited overlap in the substrates of cocaine seeking after abstinence versus extinction, and that habit learning exerts greater control over drug seeking than regions implicated in stimulus–reward associations.

286 citations


Authors

Showing all 23601 results

NameH-indexPapersCitations
Edward Giovannucci2061671179875
Ronald Klein1941305149140
Peter W.F. Wilson181680139852
Yusuke Nakamura1792076160313
John J.V. McMurray1781389184502
Nora D. Volkow165958107463
L. Joseph Melton16153197861
Gregg C. Fonarow1611676126516
Michael Boehnke152511136681
Charles B. Nemeroff14997990426
Deepak L. Bhatt1491973114652
Clifford R. Jack14096594814
Scott D. Solomon1371145103041
Karl Swedberg136706111214
Charles J. Yeo13667276424
Network Information
Related Institutions (5)
University of Alabama at Birmingham
86.7K papers, 3.9M citations

98% related

Johns Hopkins University School of Medicine
79.2K papers, 4.7M citations

98% related

University of California, San Francisco
186.2K papers, 12M citations

97% related

Baylor College of Medicine
94.8K papers, 5M citations

97% related

University of Texas Southwestern Medical Center
75.2K papers, 4.4M citations

96% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202364
2022196
20212,654
20202,488
20192,343
20182,094